High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy
- PMID: 24352348
- PMCID: PMC3952602
- DOI: 10.1093/cid/cit933
High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy
Abstract
In a randomized comparison of nevirapine or abacavir with zidovudine plus lamivudine, routine viral load monitoring was not performed, yet 27% of individuals with viral failure at week 48 experienced resuppression by week 96 without switching. This supports World Health Organization recommendations that suspected viral failure should trigger adherence counseling and repeat measurement before a treatment switch is considered.
Keywords: Africa; HIV; failure; resistance; viral resuppression.
References
-
- Mermin J, Were W, Ekwaru JP, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet. 2008;371:752–9. - PubMed
-
- United Nations Joint Programme on HIV/AIDS. Global update on HIV treatment 2013. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspubl.... Accessed 17 July 2013.
-
- World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Available at: http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html. Accessed 14 July 2013.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
